All Pharma News
Vir Biotechnology Receives FDA IND Clearance for for Tobevibart and Elebsiran

Vir Biotechnology Receives FDA IND Clearance for for Tobevibart and Elebsiran
BUSINESSWIRE
26 Jun 2024
Share Share
Vir keeps pressure on Gilead with midphase hepatitis D data

Vir keeps pressure on Gilead with midphase hepatitis D data
Nick Paul Taylor FIERCE BIOTECH
05 Jun 2024
Share Share
Tobevibart: Monotherapy/Combo Achieved Virologic Response In Hepatitis D

Tobevibart: Monotherapy/Combo Achieved Virologic Response In Hepatitis D
BUSINESSWIRE
05 Jun 2024
Share Share
Vir Biotech At Goldman Sachs Healthcare Conference 2024

Vir Biotech At Goldman Sachs Healthcare Conference 2024
BUSINESSWIRE
29 May 2024
Share Share
Vir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical Officer

Vir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical Officer
BUSINESSWIRE
29 May 2024
Share Share
Vir Biotechnology to Host 2024 Annual Meeting of Stockholders

Vir Biotechnology to Host 2024 Annual Meeting of Stockholders
BUSINESSWIRE
23 May 2024
Share Share
Vir`s Hepatitis Delta & B Data Accepted At EASL 2024

Vir`s Hepatitis Delta & B Data Accepted At EASL 2024
BUSINESSWIRE
22 May 2024
Share Share
Vir`s SOLSTICE Data Featured At EASL 2024

Vir`s SOLSTICE Data Featured At EASL 2024
BUSINESSWIRE
21 May 2024
Share Share
Vir Provides Corporate Update, Q1 2024 Financial Results

Vir Provides Corporate Update, Q1 2024 Financial Results
BUSINESSWIRE
02 May 2024
Share Share
Vir Biotechnology to Participate in BofA Healthcare Conference

Vir Biotechnology to Participate in BofA Healthcare Conference
BUSINESSWIRE
30 Apr 2024
Share Share